Brief: Vaxcyte Q1 net loss USD 60.462 million
May 8 (Reuters) - Vaxcyte Q1 operating expenses USD 71.192 million. * Q1 net income USD -60.462 million * Q1 cash & investments USD 949.853 million * Q1 EPS USD -0.7
May 8 (Reuters) - Vaxcyte Q1 operating expenses USD 71.192 million. * Q1 net income USD -60.462 million * Q1 cash & investments USD 949.853 million * Q1 EPS USD -0.7